Senior Correspondent, bdnews24.com Published: 06 Jul 2021 11:24 AM BdST Updated: 06 Jul 2021 11:24 AM BdST
Bangladesh is likely to receive one million Oxford-AstraZeneca vaccine doses under the COVAX system in July. ); }
Separately, it may receive an unspecified consignment of Oxford vaccine doses from the Serum Institute of India in August, according to Health Minister Zahid Maleque.
“The local representative of the Serum Institute said they ll start sending vaccine doses in August. Though they haven t mentioned the number of doses to be sent, they assured us it won t be a small consignment, he said.
Bangladesh started its mass vaccination campaign in February, using the COVISHIELD vaccine developed by the University of Oxford and Anglo-Swedish company AstraZeneca. But the programme was subsequently halted after India banned vaccine exports
Beximco seeks govt initiative to import vaccines from India prothomalo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prothomalo.com Daily Mail and Mail on Sunday newspapers.
Uncertainty over Serum vaccine supply to Bangladesh grows
Govt yet to receive 50 lakh doses from Serum scheduled for March
Manzur H Maswood | Published: 23:30, Apr 01,2021 | Updated: 23:55, Apr 01,2021
Uncertainty over the COVID-19 vaccine supply to Bangladesh by Serum Institute of India has increased as the Indian manufacturer failed to supply the committed 50 lakh doses of the Oxford-AstraZeneca-developed vaccine in March.
Serum has also kept Bangladesh authorities in dark about when and how many doses of the vaccine it will send in the next consignment although the country has a shortage of vaccine doses to continue its vaccination programme, including the beginning of the second dose administration on April 8.
4 Min Read
NEW DELHI (Reuters) - Bangladesh’s Beximco Pharmaceuticals will buy up to 3 million doses of the AstraZeneca vaccine from Serum Institute of India at about $8 each for sale on the private market, Beximco’s chief operating officer told Reuters.
FILE PHOTO: A vial and sryinge are seen in front of a displayed AstraZeneca logo in this illustration taken January 11, 2021. REUTERS/Dado Ruvic/Illustration
The COO, Rabbur Reza, said that was about twice the price of around $4 that Beximco had agreed for separate supplies of 5 million doses a month, over the first half of the year, for the Bangladeshi government’s subsidised mass-vaccination programme.
Bangladesh wants to buy up to 40 million more doses of the AstraZeneca coronavirus vaccine from the Serum Institute of India (SII), its health secretary said on Thursday, potentially more than doubling its purchases.